Johnson & Johnson can deliver 20 million doses of its single-shot coronavirus vaccine to the U.S. government by the end of March, an executive will testify tomorrow.
“Assuming necessary regulatory approvals relating to our manufacturing processes, our plan is to begin shipping immediately upon emergency use authorization, and deliver enough single-doses by the end of March to enable the vaccination of more than 20 million Americans,” Johnson & Johnson’s Richard Nettles, vice president of medical affairs for the company’s pharmaceutical unit Janssen, will tell a House Energy & Commerce subcommittee Tuesday.
